Boothbay Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Boothbay Fund Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.84M	Buy	+145,700	New	+$8.49M	0.11%	166
2025 Q4	–	Sell	-291,200	Closed	-$13.1M	–	1991
2025 Q3	$13.1M	Buy	+291,200	New	+$13.6M	0.19%	101
2023 Q2	–	Sell	-71,300	Closed	-$4.94M	–	1843
2023 Q1	$4.94M	Buy	+71,300	New	+$5.03M	0.1%	255
2022 Q4	–	Sell	-3,800	Closed	-$270K	–	2018
2022 Q3	$270K	Sell	3,800 -26,000	-87%	-$1.89M	0.01%	1604
2022 Q2	$2.29M	Buy	29,800 +20,900	+235%	+$1.59M	0.06%	498
2022 Q1	$650K	Buy	+8,900	New	+$598K	0.02%	1159
2019 Q2	–	Sell	-293	Closed	-$1.4M	–	752
2019 Q1	$1.4M	Sell	293 -119	-29%	-$5.93K	0.14%	167
2018 Q4	$2.14M	Buy	+412	New	+$22.1K	0.31%	61
2018 Q1	–	Sell	-586	Closed	-$3.59M	–	704
2017 Q4	$3.59M	Buy	+586	New	+$36.7K	0.53%	44

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's BMY Position: Q1 2026 in Review

Boothbay Fund Management increased its Bristol-Myers Squibb (BMY) stake by 667% in Q1 2026, buying an estimated $2.77M and bringing the position to 54,567 shares worth $3.31M. The position accounts for 0.04% of the portfolio, ranked #437.

Boothbay Fund Management first reported a position in BMY in Q1 2016 and has held it in 25 quarters since. The position peaked at $5.13M in Q1 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Boothbay Fund Management held 54,567 shares of Bristol-Myers Squibb worth $3.31M as of Q1 2026.
Boothbay Fund Management bought 47,450 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.77M.
Bristol-Myers Squibb made up 0.04% of Boothbay Fund Management's portfolio in Q1 2026, its #437 holding.
Boothbay Fund Management first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 25 quarters since.
Boothbay Fund Management's Bristol-Myers Squibb position peaked at $5.13M in Q1 2023.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.